Clinical Trial Update: Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating intravitreal bevacizumab for non-arteritic anterior ischemic optic neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-arteritic Anterior Ischemic Optic Neuropathy

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: Mount Sinai Hospital, Canada | Conditions: Non-arteritic Anterior Ischemic Optic Neuropathy | Phase 2 | Status: UNKNOWN